engleski

Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021

Using a multicentre test-negative study, we measured COVID-19 vaccine effectiveness (VE) against symptomatic infection. VE against symptomatic infection with SARS-CoV-2 Delta variant varied among brend, ranging from 52% to 91%.

COVID-19 ; Delta variant ; Europe ; SARS-COV-2 ; multicentre study ; vaccine efffectiveness

I-MOVE-COVID-19 and ECDC primary care study team (in addition to authors above): Katica Čusek Adamić, Ivana Ferenčak, Bernard Kaić, Mirjana Lana Kosanović Ličina, Danijela Lakošeljac, Ivana Mihin Huskić, Diana Nonković ...